Clinical trials
Terminated Triple Negative Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 15 |
| 2019 | 16 |
| 2020 | 17 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 122 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 7 |
| M.D. Anderson Cancer Center | 6 |
| National Cancer Institute (NCI) | 6 |
| Novartis Pharmaceuticals | 5 |
| Genmab | 3 |
| University of Wisconsin, Madison | 3 |
| Washington University School of Medicine | 3 |
| AbbVie | 2 |
| Barbara Ann Karmanos Cancer Institute | 2 |
| Calithera Biosciences, Inc | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 122 |
| Breast Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 39 |
| Ovarian Neoplasms | 25 |
| Squamous Cell Carcinoma of Head and Neck | 22 |
| Melanoma | 20 |
| Carcinoma, Renal Cell | 19 |
| Neoplasm Metastasis | 16 |
| Colorectal Neoplasms | 13 |
| Endometrial Neoplasms | 11 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.